AWM
PFE icon

Apollon Wealth Management’s Pfizer PFE Stock Holding History

Apollon Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Buy
168,834
+9,959
+6% +$261K 0.05% 313
2026
Q1 		$4.46M Buy
158,875
+6,652
+4% +$177K 0.07% 236
2025
Q4 		$3.79M Sell
152,223
-28,829
-16% -$727K 0.07% 247
2025
Q3 		$4.61M Sell
181,052
-6,304
-3% -$156K 0.08% 211
2025
Q2 		$4.54M Sell
187,356
-4,489
-2% -$105K 0.09% 198
2025
Q1 		$4.86M Sell
191,845
-10,183
-5% -$266K 0.11% 174
2024
Q4 		$5.36M Buy
202,028
+246
+0.1% +$6.67K 0.12% 145
2024
Q3 		$5.84M Sell
201,782
-11,718
-5% -$342K 0.17% 108
2024
Q2 		$5.97M Sell
213,500
-11,525
-5% -$317K 0.18% 104
2024
Q1 		$6.24M Buy
225,025
+36,424
+19% +$1.01M 0.2% 94
2023
Q4 		$5.43M Buy
188,601
+8,457
+5% +$256K 0.19% 96
2023
Q3 		$5.98M Sell
180,144
-4,734
-3% -$167K 0.3% 64
2023
Q2 		$6.78M Buy
184,878
+8,424
+5% +$328K 0.33% 60
2023
Q1 		$7.2M Sell
176,454
-4,323
-2% -$187K 0.44% 43
2022
Q4 		$9.26M Buy
180,777
+16,184
+10% +$776K 0.66% 21
2022
Q3 		$7.2M Buy
164,593
+248
+0.2% +$12.1K 0.59% 27
2022
Q2 		$8.62M Buy
164,345
+4,139
+3% +$211K 0.72% 21
2022
Q1 		$8.29M Sell
160,206
-9,970
-6% -$517K 0.59% 26
2021
Q4 		$10M Buy
170,176
+66,309
+64% +$3.29M 0.75% 19
2021
Q3 		$4.47M Buy
103,867
+59,397
+134% +$2.63M 0.61% 33
2021
Q2 		$1.74M Sell
44,470
-3,671
-8% -$143K 0.31% 56
2021
Q1 		$1.74M Buy
48,141
+39,538
+460% +$1.4M 0.34% 58
2020
Q4 		$317K Sell
8,603
-12,087
-58% -$443K 0.09% 154
2020
Q3 		$720K Buy
20,690
+7,567
+58% +$265K 0.32% 73
2020
Q2 		$407K Buy
+13,123
New +$446K 0.22% 61
2020
Q1 		– Sell
-5,648
Closed -$211K – 76
2019
Q4 		$211K Buy
+5,648
New +$201K 0.19% 68
2019
Q3 		– Sell
-1,241
Closed -$51K – 95
2019
Q2 		$51K Buy
+1,241
New +$49.3K 0.06% 96

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Apollon Wealth Management's PFE Position: Q2 2026 in Review

Apollon Wealth Management increased its Pfizer (PFE) stake by 6.3% in Q2 2026, buying an estimated $261K and bringing the position to 168,834 shares worth $4.07M. The position accounts for 0.05% of the portfolio, ranked #313.

Apollon Wealth Management first reported a position in PFE in Q2 2019 and has held it in 27 quarters since. The position peaked at $10M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Apollon Wealth Management held 168,834 shares of Pfizer worth $4.07M as of Q2 2026.
  • Apollon Wealth Management bought 9,959 Pfizer shares in Q2 2026, an estimated $261K.
  • Pfizer made up 0.05% of Apollon Wealth Management's portfolio in Q2 2026, its #313 holding.
  • Apollon Wealth Management first reported a position in Pfizer in Q2 2019 and has held it in 27 quarters since.
  • Apollon Wealth Management's Pfizer position peaked at $10M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.